? ? Our research has shown that systemic lupus erythematosus (SLE), one of the most common autoimmune diseases in women, is associated with cancer. By collaborating with researchers worldwide, we have assembled the largest-ever cohort of SLE patients and reported that these patients have an almost 4-fold increased risk of developing lymphoma. However, the reasons for this are not known; the association may be due to the immune system over-activity of SLE itself, the medications used in its treatment, genetic/ environmental factors, or viral infections. Our current application defines an innovative research plan to assess the effect of SLE disease activity on lymphoma development, through a review of lymphoma cases arising in SLE patients. First, we will enlarge our previous cohort so that more cases of lymphoma can be identified. Then, for each lymphoma case identified in our international SLE cohort, controls without cancer will be selected from the cohort. Lupus disease activity will then be compared between cases and controls to determine if patients with higher disease activity are more likely to develop lymphoma. Additionally, by comparing the clinical and pathological features of these lymphomas developing in SLE to those in the general population, we will learn more about the role of SLE activity in increasing cancer risk. Our proposed project will help identify patients at highest risk for lymphoma and provide guidance regarding initiation and maintenance of therapy to control SLE. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Research Grants (R03)
Project #
1R03CA128052-01
Application #
7264430
Study Section
Special Emphasis Panel (ZCA1-SRRB-F (J1))
Program Officer
Kasten-Sportes, Carol H
Project Start
2007-09-01
Project End
2009-08-31
Budget Start
2007-09-01
Budget End
2008-08-31
Support Year
1
Fiscal Year
2007
Total Cost
$54,000
Indirect Cost
Name
Mcgill University Health Center Research Institute
Department
Type
DUNS #
201923179
City
Montreal
State
PQ
Country
Canada
Zip Code
H3 2-R9
Bernatsky, Sasha; Ramsey-Goldman, Rosalind; Joseph, Lawrence et al. (2014) Lymphoma risk in systemic lupus: effects of disease activity versus treatment. Ann Rheum Dis 73:138-42
Lu, Mary; Bernatsky, Sasha; Ramsey-Goldman, Rosalind et al. (2013) Non-lymphoma hematological malignancies in systemic lupus erythematosus. Oncology 85:235-40
Bernatsky, Sasha; Ramsey-Goldman, Rosalind; Labrecque, Jeremy et al. (2013) Cancer risk in systemic lupus: an updated international multi-centre cohort study. J Autoimmun 42:130-5
Bernatsky, S; Ramsey-Goldman, R; Gordon, C et al. (2011) Prostate cancer in systemic lupus erythematosus. Int J Cancer 129:2966-9
Kiss, Emese; Kovacs, Laszlo; Szodoray, Peter (2010) Malignancies in systemic lupus erythematosus. Autoimmun Rev 9:195-9